MXI1 and prostate carcinoma: Importantly for six of the eight candidates, (TRIB1, PCA3, GRHL2, ACTG2, GSN, and MXI1) we were able to confirm the differential expression of the genes that harbor these STRs using a large dataset of prostate cancers compared to adjacent non-malignant cells.